Vanderbilt University Medical Center

Dr. James Crowe, Robert Carnahan and their colleagues in the Vanderbilt Vaccine Center won the Gold medal in the 2022 R&D 100 awards for their discovery and development of long-acting antibodies that protect against COVID-19. The discovery of these antibodies has led to the development of Evusheld, pre-exposure therapy to prevent COVID-19 for adults and children over 12 with compromised immune systems or a history of severe adverse reactions to a COVID-19 vaccine. Read More

The U.S. Food and Drug Administration is expected to authorize Pfizer and Moderna’s COVID-19 vaccines for children as young as 6 months old. Read More

The U.S. Food and Drug Administration granted emergency use authorization Dec. 8 to the global biopharmaceutical company AstraZeneca for a long-acting antibody combination that protects against COVID-19, discovered last year at Vanderbilt University Medical Center. Read More

Vanderbilt University has updated its COVID-19 health and safety protocols in accordance with a new executive order issued by the White House. Read More

As head of the Metro Nashville Coronavirus Task Force, Jahangir has helped coordinate local health systems and community groups, addressed the city at daily media briefings, set up COVID test sites and advised policymakers on combatting the virus, all while maintaining his normal duties at Vanderbilt. Read More

The Curb Center for Art, Enterprise and Public Policy and Vanderbilt’s Master of Public Health Program will open the Art of Healing Exposition on Friday, Sept. 17, featuring works from the World Health Organization’s Art to Act for Health initiative as well as Nashville-area artists. Read More

Biomedical informatics is a science that draws connections between data and medicine, whether those data concern diseases, health care processes or human biology in the form of genomics and proteomics. Everyone who studies health records has the same goal: more precise medicine, leading to improved patient outcomes. Read More